2013 Lung Cancer Research Foundation Annual Grant Program
Matthew Niederst, PhD
Massachusetts General Hospital/Harvard Medical School
Research Project:
Developing Therapeutic Strategies to Overcome NSCLC to SCLC Transformation as a Resistance Mechanism in Lung Cancer
Summary:
Dr. Niederst’s study will build upon findings from the previous year to better understand how NSCLC and SCLC overcome EGFR inhibition and develop a strategy to treat the resistant tumors.